公开(公告)号：EP4230211A1

公开(公告)日：2023-08-23

申请号：EP20964393.1

申请日：2020-12-04

申请人： Laboratorios Silanes, S.A. de C.V.

发明人： MUÑOZ MARTINEZ, Cecilia Jannette ,  FARFÁN SALAZAR, Claudia Delfina ,  ESPINOZA LEÓN, Sixto Serafín ,  GONZÁLEZ CANUDAS, Jorge Alejandro ,  OLLERVIDES RUBIO, Paola Yazmín

IPC分类号： A61K31/573 ,  A61K31/4545 ,  A61P37/08

摘要： The present invention combines in only one dosage unit the drugs desloratadine and betamethasone, which represents a set of important technological challenges due to the physicochemical properties and the difference in dosage to ensure the obtaining of a stable product for the treatment of allergic and inflammatory processes in a subject.

公开(公告)号：EP4268813A1

公开(公告)日：2023-11-01

申请号：EP20964394.9

申请日：2020-12-04

申请人： Laboratorios Silanes, S.A. de C.V.

发明人： MUÑOZ MARTÍNEZ, Cecilia Jannette ,  GONZÁLEZ CANUDAS, Jorge Alejandro ,  OLLERVIDES RUBIO, Paola Yazmín ,  ESPINOZA LEÓN, Sixto Serafín ,  FARFÁN SALAZAR, Claudia Delfina

IPC分类号： A61K31/192 ,  A61K31/51 ,  A61K31/4415 ,  A61K31/714 ,  A61P29/00

摘要： This invention is about the manufacture of fixed-dose combination drug products to be used as an anti-inflammatory and antineuritic agents for the control and management of pain, particularly moderate to severe intensity acute pain of different etiologies resulting from peripheral neuropathies, low back pain, sciatica, neck pain, radiculitis, post-herpetic neuralgia, spondylitis, carpal tunnel syndrome, fibromyalgia, etc., of different etiologies such as inflammatory, drug, diabetic, alcoholic, or nutritional etiology, etc. These fixed-dose combination drug products contain a therapeutically effective amount of (a) a non-steroidal anti-inflammatory drug (NSAID) or a pharmaceutically acceptable salt thereof, (b) an antineuritic agent or a pharmaceutically acceptable salt thereof, and (c) at least one pharmaceutically acceptable amount of a pharmaceutically acceptable excipient.

公开(公告)号：EP4180036A1

公开(公告)日：2023-05-17

申请号：EP20956398.0

申请日：2020-09-29

申请人： Laboratorios Silanes, S.A. de C.V.

发明人： OLLERVIDES RUBIO, Paola Yazmín ,  GONZÁLEZ CANUDAS, Jorge Alejandro ,  ESPINOZA LEÓN, Sixto Serafín ,  FARFÁN SALAZAR, Claudia Delfina

IPC分类号： A61K31/40 ,  A61K31/216 ,  A61P3/06

摘要： This invention combines in a single dosage form the active principles, atorvastatin and fenofibrate, which represents a set of important technological challenges due to the physicochemical properties and the difference in dosage to ensure obtaining a stable product in the treatment of hyperlipidemia and the prevention of cardiovascular diseases.